• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HVEM 结构及其突变体揭示了与 LIGHT 和 BTLA/CD160 结合的不同功能。

HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160.

机构信息

Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY.

La Jolla Institute for Immunology, La Jolla, CA.

出版信息

J Exp Med. 2021 Dec 6;218(12). doi: 10.1084/jem.20211112. Epub 2021 Oct 28.

DOI:10.1084/jem.20211112
PMID:34709351
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8558838/
Abstract

HVEM is a TNF (tumor necrosis factor) receptor contributing to a broad range of immune functions involving diverse cell types. It interacts with a TNF ligand, LIGHT, and immunoglobulin (Ig) superfamily members BTLA and CD160. Assessing the functional impact of HVEM binding to specific ligands in different settings has been complicated by the multiple interactions of HVEM and HVEM binding partners. To dissect the molecular basis for multiple functions, we determined crystal structures that reveal the distinct HVEM surfaces that engage LIGHT or BTLA/CD160, including the human HVEM-LIGHT-CD160 ternary complex, with HVEM interacting simultaneously with both binding partners. Based on these structures, we generated mouse HVEM mutants that selectively recognized either the TNF or Ig ligands in vitro. Knockin mice expressing these muteins maintain expression of all the proteins in the HVEM network, yet they demonstrate selective functions for LIGHT in the clearance of bacteria in the intestine and for the Ig ligands in the amelioration of liver inflammation.

摘要

HVEM 是一种 TNF(肿瘤坏死因子)受体,参与涉及多种细胞类型的广泛免疫功能。它与 TNF 配体 LIGHT 以及免疫球蛋白 (Ig) 超家族成员 BTLA 和 CD160 相互作用。在不同环境下评估 HVEM 与特定配体结合的功能影响,由于 HVEM 和 HVEM 结合伙伴的多种相互作用而变得复杂。为了剖析多种功能的分子基础,我们确定了晶体结构,揭示了 HVEM 与 LIGHT 或 BTLA/CD160 结合的不同表面,包括人 HVEM-LIGHT-CD160 三元复合物,其中 HVEM 同时与两个结合伙伴相互作用。基于这些结构,我们生成了体外选择性识别 TNF 或 Ig 配体的小鼠 HVEM 突变体。表达这些突变体的基因敲入小鼠保留了 HVEM 网络中所有蛋白质的表达,但它们在清除肠道细菌方面表现出 LIGHT 的选择性功能,在改善肝脏炎症方面表现出 Ig 配体的选择性功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/acabbf618881/JEM_20211112_FigS5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/860dafeb72cd/JEM_20211112_GA.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/f540f20a5137/JEM_20211112_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/5b3d7894e655/JEM_20211112_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/f8822835c99c/JEM_20211112_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/fdfc8f03c896/JEM_20211112_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/93a3b5687515/JEM_20211112_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/b97c1eab4344/JEM_20211112_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/7562329c6d71/JEM_20211112_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/e2a139d373b1/JEM_20211112_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/7f1cefca4400/JEM_20211112_FigS4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/c4937fada9ae/JEM_20211112_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/acabbf618881/JEM_20211112_FigS5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/860dafeb72cd/JEM_20211112_GA.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/f540f20a5137/JEM_20211112_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/5b3d7894e655/JEM_20211112_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/f8822835c99c/JEM_20211112_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/fdfc8f03c896/JEM_20211112_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/93a3b5687515/JEM_20211112_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/b97c1eab4344/JEM_20211112_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/7562329c6d71/JEM_20211112_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/e2a139d373b1/JEM_20211112_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/7f1cefca4400/JEM_20211112_FigS4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/c4937fada9ae/JEM_20211112_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7586/8558838/acabbf618881/JEM_20211112_FigS5.jpg

相似文献

1
HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160.HVEM 结构及其突变体揭示了与 LIGHT 和 BTLA/CD160 结合的不同功能。
J Exp Med. 2021 Dec 6;218(12). doi: 10.1084/jem.20211112. Epub 2021 Oct 28.
2
Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT.疱疹病毒进入介体被人免疫抑制受体 CD160 识别的分子基础及其与共刺激分子 BTLA 和 LIGHT 的关系。
J Mol Biol. 2011 Nov 4;413(4):762-72. doi: 10.1016/j.jmb.2011.09.018. Epub 2011 Sep 19.
3
Redesigning HVEM Interface for Selective Binding to LIGHT, BTLA, and CD160.重新设计 HVEM 界面以选择性结合 LIGHT、BTLA 和 CD160。
Structure. 2020 Nov 3;28(11):1197-1205.e2. doi: 10.1016/j.str.2020.07.013. Epub 2020 Aug 13.
4
A herpesvirus entry mediator mutein with selective agonist action for the inhibitory receptor B and T lymphocyte attenuator.一种疱疹病毒进入介质突变体,对抑制性受体 B 和 T 淋巴细胞衰减因子具有选择性激动作用。
J Biol Chem. 2017 Dec 22;292(51):21060-21070. doi: 10.1074/jbc.M117.813295. Epub 2017 Oct 23.
5
Herpes Simplex Virus 1 Latency and the Kinetics of Reactivation Are Regulated by a Complex Network of Interactions between the Herpesvirus Entry Mediator, Its Ligands (gD, BTLA, LIGHT, and CD160), and the Latency-Associated Transcript.单纯疱疹病毒 1 潜伏和再激活的动力学受疱疹病毒进入介质与其配体(gD、BTLA、LIGHT 和 CD160)以及潜伏相关转录物之间复杂相互作用网络的调节。
J Virol. 2018 Nov 27;92(24). doi: 10.1128/JVI.01451-18. Print 2018 Dec 15.
6
Structural Basis of CD160:HVEM Recognition.CD160:HVEM 识别的结构基础。
Structure. 2019 Aug 6;27(8):1286-1295.e4. doi: 10.1016/j.str.2019.05.010. Epub 2019 Jun 20.
7
The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation.CD160、BTLA、LIGHT/HVEM信号通路:调节T细胞活化的双向开关
Immunol Rev. 2009 May;229(1):244-58. doi: 10.1111/j.1600-065X.2009.00783.x.
8
HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT.HVEM,一种共信号分子开关,及其与BTLA、CD160和LIGHT的相互作用。
Cell Mol Immunol. 2019 Jul;16(7):679-682. doi: 10.1038/s41423-019-0241-1. Epub 2019 Jun 3.
9
The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation.疱疹病毒进入介体(TNFRSF14)信号网络在免疫调节中的作用。
Immunol Rev. 2011 Nov;244(1):169-87. doi: 10.1111/j.1600-065X.2011.01064.x.
10
CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells.疱疹病毒进入介体激活 CD160 增强 NK 细胞的炎症细胞因子产生和细胞溶解功能。
J Immunol. 2013 Jul 15;191(2):828-36. doi: 10.4049/jimmunol.1300894. Epub 2013 Jun 12.

引用本文的文献

1
Internal regulation between constitutively expressed T cell co-inhibitory receptors BTLA and CD5 and tolerance in recent thymic emigrants.固有表达的 T 细胞共抑制受体 BTLA 和 CD5 之间的内在调节与近期胸腺迁出细胞中的耐受
Open Biol. 2024 Oct;14(10):240178. doi: 10.1098/rsob.240178. Epub 2024 Oct 30.
2
Therapeutic targets of armored chimeric antigen receptor T cells navigating the tumor microenvironment.穿越肿瘤微环境的武装嵌合抗原受体T细胞的治疗靶点。
Exp Hematol Oncol. 2024 Sep 30;13(1):96. doi: 10.1186/s40164-024-00564-w.
3
Proteomic Investigation of Immune Checkpoints and Some of Their Inhibitors.

本文引用的文献

1
Redesigning HVEM Interface for Selective Binding to LIGHT, BTLA, and CD160.重新设计 HVEM 界面以选择性结合 LIGHT、BTLA 和 CD160。
Structure. 2020 Nov 3;28(11):1197-1205.e2. doi: 10.1016/j.str.2020.07.013. Epub 2020 Aug 13.
2
CD160 serves as a negative regulator of NKT cells in acute hepatic injury.CD160 作为急性肝损伤中 NKT 细胞的负调节剂。
Nat Commun. 2019 Jul 22;10(1):3258. doi: 10.1038/s41467-019-10320-y.
3
Structural Basis of CD160:HVEM Recognition.CD160:HVEM 识别的结构基础。
免疫检查点及其抑制剂的蛋白质组学研究。
Int J Mol Sci. 2024 Aug 27;25(17):9276. doi: 10.3390/ijms25179276.
4
Pan-cancer analysis of immune checkpoint receptors and ligands in various cells in the tumor immune microenvironment.泛癌症分析肿瘤免疫微环境中各种细胞中的免疫检查点受体和配体。
Aging (Albany NY). 2024 Aug 7;16(15):11683-11728. doi: 10.18632/aging.206053.
5
Multilayered Computational Framework for Designing Peptide Inhibitors of HVEM-LIGHT Interaction.用于设计 HVEM-LIGHT 相互作用肽抑制剂的多层计算框架。
J Phys Chem B. 2024 Jul 18;128(28):6770-6785. doi: 10.1021/acs.jpcb.4c02255. Epub 2024 Jul 3.
6
The role of the BTLA-HVEM complex in the pathogenesis of breast cancer.BTLA-HVEM 复合物在乳腺癌发病机制中的作用。
Breast Cancer. 2024 May;31(3):358-370. doi: 10.1007/s12282-024-01557-7. Epub 2024 Mar 14.
7
Causal effects and immune cell mediators between prescription analgesic use and risk of infectious diseases: a Mendelian randomization study.处方类镇痛药使用与传染病风险之间的因果效应和免疫细胞介导物:一项孟德尔随机化研究。
Front Immunol. 2023 Dec 21;14:1319127. doi: 10.3389/fimmu.2023.1319127. eCollection 2023.
8
Immune activation of the p75 neurotrophin receptor: implications in neuroinflammation.p75神经营养因子受体的免疫激活:对神经炎症的影响
Front Mol Neurosci. 2023 Dec 1;16:1305574. doi: 10.3389/fnmol.2023.1305574. eCollection 2023.
9
Investigation of LGALS2 expression in the TCGA database reveals its clinical relevance in breast cancer immunotherapy and drug resistance.在 TCGA 数据库中调查 LGALS2 的表达情况,揭示其在乳腺癌免疫治疗和耐药性中的临床相关性。
Sci Rep. 2023 Oct 14;13(1):17445. doi: 10.1038/s41598-023-44777-1.
10
Expression of HPV-16 E6 and E7 oncoproteins alters developmental cycle and induces increased levels of immune regulatory molecules.人乳头瘤病毒16型E6和E7癌蛋白的表达改变发育周期并诱导免疫调节分子水平升高。
Front Cell Infect Microbiol. 2023 Sep 8;13:1214017. doi: 10.3389/fcimb.2023.1214017. eCollection 2023.
Structure. 2019 Aug 6;27(8):1286-1295.e4. doi: 10.1016/j.str.2019.05.010. Epub 2019 Jun 20.
4
The HVEM-BTLA Axis Restrains T Cell Help to Germinal Center B Cells and Functions as a Cell-Extrinsic Suppressor in Lymphomagenesis.HVEM-BTLA 轴抑制 T 细胞向生发中心 B 细胞的辅助作用,并在淋巴瘤发生中作为细胞外在的抑制因子发挥作用。
Immunity. 2019 Aug 20;51(2):310-323.e7. doi: 10.1016/j.immuni.2019.05.022. Epub 2019 Jun 13.
5
CD160 Stimulates CD8 T Cell Responses and Is Required for Optimal Protective Immunity to .CD160刺激CD8 T细胞反应,并且是对……产生最佳保护性免疫所必需的。
Immunohorizons. 2018 Aug 27;2(7):238-250. doi: 10.4049/immunohorizons.1800039.
6
HVEM network signaling in cancer.HVEM 网络信号在癌症中的作用。
Adv Cancer Res. 2019;142:145-186. doi: 10.1016/bs.acr.2019.01.004. Epub 2019 Feb 27.
7
The Tumor Necrosis Factor Superfamily Members TNFSF14 (LIGHT), Lymphotoxin β and Lymphotoxin β Receptor Interact to Regulate Intestinal Inflammation.肿瘤坏死因子超家族成员 TNFSF14(LIGHT)、淋巴毒素β和淋巴毒素β受体相互作用调节肠道炎症。
Front Immunol. 2018 Nov 22;9:2585. doi: 10.3389/fimmu.2018.02585. eCollection 2018.
8
LIGHT-HVEM Signaling in Innate Lymphoid Cell Subsets Protects Against Enteric Bacterial Infection.先天淋巴细胞亚群中的 LIGHT-HVEM 信号传递可预防肠道细菌感染。
Cell Host Microbe. 2018 Aug 8;24(2):249-260.e4. doi: 10.1016/j.chom.2018.07.008.
9
LIGHT-HVEM signaling in keratinocytes controls development of dermatitis.角质细胞中的 LIGHT-HVEM 信号转导控制着皮炎的发生。
J Exp Med. 2018 Feb 5;215(2):415-422. doi: 10.1084/jem.20170536. Epub 2018 Jan 16.
10
HVEM Imprints Memory Potential on Effector CD8 T Cells Required for Protective Mucosal Immunity.HVEM在保护性黏膜免疫所需的效应性CD8 T细胞上印记记忆潜能。
J Immunol. 2017 Oct 15;199(8):2968-2975. doi: 10.4049/jimmunol.1700959. Epub 2017 Sep 1.